HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.

View/ Open
Date
2009Author
Khurana, Surender.
Norris, Philip J.
Busch, Michael P.
Haynes, Barton F.
Park, Susan.
Sasono, Pretty.
Mlisana, Koleka Patience.
Abdool Karim, Salim Safurdeen.
Hecht, Frederick M.
Mulenga, Joseph.
Chomba, Elwyn.
Hunter, Eric.
Allen, Susan.
Nemo, George.
Rodriguez-Chavez, Isaac R.
Women’s Interagency HIV Study Collaborative Study Group.
Margolick, Joseph B.
Golding, Hana.
Metadata
Show full item recordAbstract
HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 and gp41 peptides, designed to differentiate between vaccine-induced antibodies and true infections. A rapid test version of the HIV-Selectest was developed. Both assays detected HIV antibodies in men and women within 2 to 4 weeks of infection, with sensitivity similar to third-generation EIAs.